News

Study shows no association between the use of protein supplements and semen quality characteristics

May 14, 2020

On the 6th of May, Fertility & Sterility under the American Society of Reproductive Medicine published the study ‘Semen quality among young healthy men taking protein supplements’.

According to a newly published report by the Danish National Food Institute, 16% of all Danes aged 15-55 years reported having used sports nutrition products during the previous month. Some of these men may later be part of the infertility statistics and wonder, if the use of protein supplements (PS) played a role.

“Our study showed no association between use of PS and semen quality characteristics, which is good news to any men worrying about this. However, we still encourage others to repeat the study, as even a small harmful effect would have a large impact on the population level because of the widespread use of PS among young men,” says Sandra Søgaard Tøttenborg, reproductive and environmental epidemiologist as well as Principal Investigator on the FEPOS project and ReproUnion.

The study used data from the Fetal Programming of Semen Quality (FEPOS) cohort, which ReproUnion co-funded and reported about in December 2019, when it reached 1000 participants. FEPOS is a subcohort of young adult sons born to women enrolled in the Danish National Birth Cohort (DNBC) in connection with their pregnancy in 1996-2002.

“We studied the association between use of PS and semen quality among 778 unselected young men. From April 2017 to March 2019, we invited the sons to complete a comprehensive questionnaire on lifestyle, health, and physical activity, including use of PS, to undergo a clinical examination, and to provide a semen sample,” says Sandra Søgaard Tøttenborg.

There was also collaboration across the border with partners in ReproUnion. The FEPOS technologists participated in an ongoing quality control program with the Reproductive Medicine Centre in Malmö. The Centre was also responsible for sperm morphology analysis (percentage of normal sperm).

You can find the publication of the study here.

MORE NEWS


RUBIC Seminar – The Team Makes the Dream Work

On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient recruitment, clinical visits, sample preparation, and data analysis as well as other colleagues in contact with RUBIC in their...

read more

Defective sperm doubles the risk of preeclampsia

We’re excited to share new findings from Lund University, led by ReproUnion researcher Aleksander Giwercman. For the first time, researchers have linked specific sperm defects to pregnancy complications and adverse effects on the child’s health. The study shows that...

read more

Tour de Health

Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his presence highlights the growing political attention on reproductive...

read more

ReproUnion Researchers at the BII Summerschool!

This week, 5 of our brilliant ReproUnion researchers— Angel Elenkov, Ann Holm Hansen & Lærke Priskorn focusing on male infertility and Hannah Schorle & Judith Bello Rodríguez focusing on female infertility - are diving deep into the BII Summerschool:...

read more